Back

Antithrombotic therapy in patients with transcatheter aortic valve implantation: Balancing risks with benefits.

28 August 2021 (13:22 - 13:37)
Organised by:
Congress Presentation Part of: Optimising oral anticoagulation for atrial fibrillation patients undergoing cardiac interventions in 2021: From evidence to practice Atrial Fibrillation (AF) Open Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Jurrien M ten Berg

St Antonius Hospital, Nieuwegein (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Welcome: The shifting risk/benefit balance of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation and cardiac interventions.
Professor I. Van Gelder (Groningen, NL)
Video
Presentation thumbnail
Building the evidence base for cardiac interventions in non-valvular atrial fibrillation.
Professor R. Lopes (Durham, US)
Video
Presentation thumbnail
Panel Q&A.

Access the full session

Session thumbnail
Optimising oral anticoagulation for atrial fibrillation patients undergoing cardiac interventions in 2021: From evidence to practice
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 13:22 CET
You may be interested in
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources